Press Releases

Tidewater Inc. (NYSE:TDW) ("Tidewater" or the "Company") announced today that it will release financial results for the three months ending March 31, 2026, on Monday, May 4, 2026 after market close. An earnings conference call has been scheduled for Tuesday, May 5, 2026, at 8:00 a.m. Central Time, during which President and Chief Executive Officer Quintin Kneen will discuss results for the three months ending March 31, 2026. Investors and interested parties may listen to the earnings conference call via telephone by calling +1.800.715.9871 if calling from the U.S. or Canada (+1.647.932.3411 if calling from outside the U.S.) and provide Conference ID: 8745688 prior to the scheduled start t

WAYNE, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide the full results from its Phase 1a single and multiple ascending dose trial of its anti-TSLP/IL-4R bispecific antibody ATI-052 and the results of its lead indication selection process for its ITK/JAK3 Inhibitor ATI-2138 before the opening of the financial markets tomorrow, April 28, 2026. Aclaris will host a webcast and conference call with slides tomorrow morning at 8:30 AM EST to discuss these updates. The live and archived webcast will be a

First Quarter 2026 Highlights: Net interest margin of 4.25% Loan growth of 16.2%, annualized 24.7% noninterest income to total revenue1 Net income of $21.6 million, $0.76 per diluted share (adjusted, $23.7 million, $0.84 per diluted share, see "Non-GAAP Financial Measures and Reconciliations" below) Return on average total assets of 1.04% (adjusted, 1.14%, see "Non-GAAP Financial Measures and Reconciliations" below) Return on average stockholders' equity of 7.47% (adjusted, 8.20%, see "Non-GAAP Financial Measures and Reconciliations" below) FirstSun Capital Bancorp ("FirstSun") (NASDAQ:FSUN) reported net income of $21.6 million for the first quarter of 2026 compared to

CHARLESTON, W.Va., April 27, 2026 /PRNewswire/ -- West Virginia American Water is pleased to announce a $500,000 infrastructure upgrade project on 17th Street in Dunbar."We are committed to continued investment in our infrastructure systems across the state," said Scott Wyman, President of West Virginia American Water. "This project will benefit the Dunbar community and customers we serve and allow us to continue providing safe, clean, reliable and affordable water."The project entails replacing 800 feet of aging pipe with 6-inch and 2-inch PVC main and will occur on 17th Street between Fletcher Avenue and Route 25 – Fairlawn Avenue. It is scheduled to be completed by the end of May, and the

HAMILTON, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) ("the Bank") today announced results for the first quarter of 2026. Net income for the first quarter of 2026 was $7.6 million, or $0.30 per diluted share, compared to $9.4 million, or $0.37 per diluted share, for the first quarter of 2025. Return on average assets, return on average equity and return on average tangible equityi for the first quarter of 2026 were 0.79%, 6.89% and 7.78%, respectively, compared to 1.00%, 9.20% and 10.54%, respectively, for the first quarter of 2025. First Quarter 2026 Performance Highlights:  ●Total loans were $3.30 billion at March 31, 2026, increasing $68.1 million,

Central Garden & Pet Company (NASDAQ:CENT) (NASDAQ:CENTA) ("Central"), a leading consumer goods company in the pet and garden industries, will release its fiscal 2026 second quarter results for the period ending March 28, 2026, after market close on Wednesday, May 6, 2026. On the same day, Central will host a conference call at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time), led by CEO Niko Lahanas and CFO Brad Smith, to review these results and to provide a business update. A live webcast, replay and related materials will be available at http://ir.central.com. To join by phone, please dial +1 (201) 689-8345 for both domestic and international participants. About Central Garden & Pet

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership

Onterris, Inc. (NYSE:MONTROSE, Inc., MEG, NYSE:ONTERRIS, Inc., ONT on May 4, 2026)), a global environmental solutions company solving complex challenges for planet and progress, today announced the planned dates for its first quarter fiscal year 2026 results and conference call. On Wednesday, May 6, 2026, after the close of trading on the New York Stock Exchange, Onterris intends to release its first quarter fiscal year 2026 results. On Thursday, May 7, 2026, at 8:30 a.m. Eastern Time, Onterris plans to host a conference call to discuss these results and the forward outlook. A live webcast of the conference call will be available in the Investors section of the Onterris website at ir.

- Data underscore the differentiated capability of the clinically validated FORCE platform to cross the blood-brain barrier - WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it will present new preclinical data demonstrating the ability of the FORCE platform to cross the blood-brain barrier (BBB) and enable robust knockdown of MAPT RNA in the central nervous system (CNS) at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting being held May 11-15, 2026, in Boston, MA, and vir

Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, May 11, 2026 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's first quarter 2026 results. The Company expects to issue a news release detailing the results prior to the May 11 conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 461-5787; the dial-in number for participants in Canada is (365) 657-4084; the dial-in number for pa

Johnson & Johnson (NYSE:JNJ) will present at the Bernstein's 42nd Annual Strategic Decisions Conference on Wednesday, May 27th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available approximately 48 hours after the webcast. View source version on businesswire.com: https://www.businesswire.com/news/home/20260427510768/en/ Media contact: media-relations@its.jnj.com Investor contact: investor-relations@its.jnj.c

PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the planned retirement of Mark Hancock — PACS co-founder, first CFO, and one of the principal architects behind the company's success — on June 30, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427554117/en/Mark Hancock, PACS Group co-founder and retiring Chief Financial Officer Mr. Hancock co-founded PACS in 2013 alongside Jason Murray, PACS's Chairman and CEO, with just two post-acute care facilities in San Diego, CA. Under his leadership as CFO, PACS expanded from those two facilities to 323

CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that five abstracts have been accepted for presentation, including one oral presentation and two poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, one oral presentation at TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference, and one oral presentation at the 94th European Atherosclerosis Society (EAS) Congress. The Company is presenting new preclinical data, including data to support the potential of EDIT-401, its lead in

First Quarter of 2026 HighlightsNet earnings attributable to Nucor stockholders of $743 million, or $3.23 per diluted shareNet sales of $9.50 billionNet earnings before noncontrolling interests of $870 million; EBITDA of $1.51 billionCHARLOTTE, N.C., April 27, 2026 /PRNewswire/ -- Nucor Corporation (NYSE:NUE) today announced consolidated net earnings attributable to Nucor stockholders of $743 million, or $3.23 per diluted share, for the first quarter of 2026. Nucor reported consolidated net earnings attributable to Nucor stockholders in the fourth quarter of 2025 of $378 million, or $1.64 per diluted share (adjusted net earnings of $400 million, or $1.73 per diluted share). Nucor reported ne

LAS VEGAS, April 27, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE:GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced that its wholly-owned subsidiary Ault Global Commodities, Inc. ("AGC") has completed its first purchase of physical silver, acquiring 10,000 ounces of .999 fine silver bullion. The transaction was executed through AGC's strategic partner, Scottsdale Mint, LLLP, a leading private mint specializing in high-quality investment grade precious metals with which AGC has entered into a purchase and sale agreement (the "Agreement").

Phibro Animal Health Corporation (NASDAQ:PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications. The Brazilian Ministry of Agriculture and Livestock (MAPA) published Ordinance No. 1617 on April 27, 2026, prohibiting the importation, manufacture, marketing and use of performance enhancing feed additives containing antimicrobials classified as important in human or veterinary medicine, including virginiamycin and bacitracin. This regulation brings Brazil into alignment with regulatory approaches adopted in other global markets. This prohibition will come into effect after a tran

InTest Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor ("semi"), automotive/EV, defense/aerospace, industrial, life sciences and safety/security, announced it will release its first quarter 2026 financial results before the opening of financial markets on Tuesday, May 5, 2026. The Company will host a conference call and webcast that day to review its financial and operating results and discuss its corporate strategies and outlook. A question-and-answer session will follow. First Quarter 2026 Conference Call Tuesday, May 5, 2026 8:30 a.m. Eastern Time Ph

Lifezone Metals Limited (NYSE:LZM) announced today that it plans to release its Q1 2026 interim financial results on April 30, 2026. Investor Webcast: April 30, 2026 / 10:00 a.m. ET | 15:00 p.m. BST Chris Showalter, CEO and Ingo Hofmaier, CFO, will be hosting a conference call and Q&A on the day. Analysts and investors can register at: Lifezone Metals Q1 2026 Interim Financial Results Webcast. If you would like to sign up for Lifezone Metals news alerts, please register here. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE:LZM) is committed to delivering cleaner and more responsible metals production and recycling. Through the application of our H

Rithm Capital and Key Joint Venture (JV) Partners Plan for Approximately $250 Million in Capital Improvements to Enhance Trophy Office Portfolio Across New York City and San Francisco, Following Record 1.74 Million Square Feet of Leasing in 2025 Rithm Capital Corp. (NYSE:RITM) ("Rithm"), a global alternative asset manager, today announced that its commercial real estate platform Paramount Group, has officially rebranded as Elecor Properties ("Elecor"), a premier real estate platform redefining the modern workplace. The new identity reflects a strategic transformation from a high quality, Class A office portfolio into an operating platform built for the next evolution of the workplace. E

Expands reach to serve small and mid-market multifamily owners and operators SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), a leading provider of smart communities and smart operations solutions for the rental housing industry, today announced the launch of its strategic value-added reseller (VAR) program. This initiative marks an expansion of SmartRent's go-to-market model and is designed to address the needs of small and mid-market rental housing owners and operators. SKBM Smart Technology, a long-time SmartRent installation provider, will be the first VAR in the program. SmartRent has a strong position among the largest multifamily portfolios, with more than 900,000 IoT